Annual CFF:
$381.23M+$294.71M(+340.66%)Summary
- As of today, SMMT annual cash from financing is $381.23 million, with the most recent change of +$294.71 million (+340.66%) on December 31, 2024.
- During the last 3 years, SMMT annual cash from financing has risen by +$303.31 million (+389.28%).
- SMMT annual cash from financing is now -38.54% below its all-time high of $620.24 million, reached on December 31, 2022.
Performance
SMMT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$34.66M+$32.14M(+1275.46%)Summary
- As of today, SMMT quarterly cash from financing is $34.66 million, with the most recent change of +$32.14 million (+1275.46%) on September 30, 2025.
- Over the past year, SMMT quarterly cash from financing has dropped by -$177.74 million (-83.68%).
- SMMT quarterly cash from financing is now -93.03% below its all-time high of $497.17 million, reached on December 31, 2022.
Performance
SMMT Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$14.59M-$177.74M(-92.41%)Summary
- As of today, SMMT TTM cash from financing is $14.59 million, with the most recent change of -$177.74 million (-92.41%) on September 30, 2025.
- Over the past year, SMMT TTM cash from financing has dropped by -$402.54 million (-96.50%).
- SMMT TTM cash from financing is now -97.75% below its all-time high of $647.48 million, reached on June 30, 2023.
Performance
SMMT TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SMMT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +340.7% | -83.7% | -96.5% |
| 3Y3 Years | +389.3% | -49.8% | -84.4% |
| 5Y5 Years | +692.6% | +10000.0% | +10000.0% |
SMMT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -38.5% | +389.3% | -93.0% | +214.5% | -97.8% | +117.3% |
| 5Y | 5-Year | -38.5% | +692.6% | -93.0% | +214.5% | -97.8% | >+9999.0% |
| All-Time | All-Time | -38.5% | >+9999.0% | -93.0% | +214.5% | -97.8% | +1208.7% |
SMMT Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $34.66M(+1275.5%) | $14.59M(-92.4%) |
| Jun 2025 | - | $2.52M(-67.2%) | $192.34M(-50.6%) |
| Mar 2025 | - | $7.68M(+125.4%) | $389.54M(+1.9%) |
| Dec 2024 | $381.23M(+340.7%) | -$30.27M(-114.2%) | $382.35M(-8.3%) |
| Sep 2024 | - | $212.41M(+6.3%) | $417.13M(+103.2%) |
| Jun 2024 | - | $199.73M(>+9900.0%) | $205.31M(+2957.1%) |
| Mar 2024 | - | $485.00K(-89.3%) | $6.72M(-92.2%) |
| Dec 2023 | $86.51M(-86.1%) | $4.51M(+671.3%) | $86.34M(-85.1%) |
| Sep 2023 | - | $585.20K(-48.3%) | $579.00M(-10.6%) |
| Jun 2023 | - | $1.13M(-98.6%) | $647.48M(+0.3%) |
| Mar 2023 | - | $80.11M(-83.9%) | $645.54M(+9.3%) |
| Dec 2022 | $620.24M(+696.0%) | $497.17M(+619.8%) | $590.61M(+533.1%) |
| Sep 2022 | - | $69.07M(+8584.2%) | $93.29M(+285.3%) |
| Jun 2022 | - | -$814.10K(-103.2%) | $24.21M(-47.0%) |
| Mar 2022 | - | $25.19M(>+9900.0%) | $45.64M(-40.2%) |
| Dec 2021 | $77.92M(+54.1%) | -$150.30K(-1195.7%) | $76.35M(-40.6%) |
| Sep 2021 | - | -$11.60K(-100.1%) | $128.55M(-0.0%) |
| Jun 2021 | - | $20.62M(-63.1%) | $128.57M(+19.0%) |
| Mar 2021 | - | $55.90M(+7.4%) | $108.01M(+107.5%) |
| Dec 2020 | $50.55M(+5.1%) | - | - |
| Dec 2020 | - | $52.05M(>+9900.0%) | $52.05M(>+9900.0%) |
| Sep 2020 | - | $100.00(-99.8%) | $3100.00(+3.3%) |
| Jun 2020 | - | $60.50K(+205.2%) | $3000.00(+105.2%) |
| Mar 2020 | - | -$57.50K(-100.2%) | -$57.50K(-100.1%) |
| Dec 2019 | $48.10M(+166.1%) | - | - |
| Jan 2019 | - | $24.70M(+4505.1%) | $42.88M(+130.1%) |
| Oct 2018 | - | -$560.80K(+48.4%) | $18.64M(-50.2%) |
| Jul 2018 | - | -$1.09M(-105.5%) | $37.44M(-2.9%) |
| Apr 2018 | - | $19.82M(+4220.0%) | $38.55M(+105.7%) |
| Jan 2018 | $18.08M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | - | $458.90K(-97.5%) | $18.74M(+2.5%) |
| Oct 2017 | - | $18.24M(>+9900.0%) | $18.28M(+4823.2%) |
| Jul 2017 | - | $27.70K(+71.0%) | $371.40K(-1.3%) |
| Apr 2017 | - | $16.20K(+1250.0%) | $376.30K(-26.6%) |
| Jan 2017 | $550.50K(-98.4%) | - | - |
| Jan 2017 | - | $1200.00(-99.6%) | $512.90K(+170.4%) |
| Oct 2016 | - | $326.30K(+900.9%) | -$728.60K(+44.6%) |
| Jul 2016 | - | $32.60K(-78.7%) | -$1.32M(-637.3%) |
| Apr 2016 | - | $152.80K(+112.3%) | -$178.50K(-100.5%) |
| Jan 2016 | $33.68M(+0.3%) | - | - |
| Jan 2016 | - | -$1.24M(-375.0%) | $32.87M(+3.6%) |
| Oct 2015 | - | -$261.10K(-122.3%) | $31.73M(+6.3%) |
| Jul 2015 | - | $1.17M(-96.5%) | $29.85M(+3.6%) |
| Apr 2015 | - | $33.20M(+1492.5%) | $28.82M(-5.5%) |
| Jan 2015 | $33.59M(+381.0%) | - | - |
| Jan 2015 | - | -$2.38M(-11.5%) | $30.48M(-7.3%) |
| Oct 2014 | - | -$2.14M(-1653.3%) | $32.86M(-6.1%) |
| Jul 2014 | - | $137.70K(-99.6%) | $35.00M(+0.4%) |
| Apr 2014 | - | $34.86M | $34.86M |
| Jan 2014 | $6.98M(-3.5%) | - | - |
| Jan 2013 | $7.23M(+232.3%) | - | - |
| Jan 2012 | $2.18M(+8714.2%) | - | - |
| Jan 2011 | $24.70K(-99.7%) | - | - |
| Jan 2010 | $8.02M(+22.0%) | - | - |
| Jan 2009 | $6.57M(+389.3%) | - | - |
| Jan 2008 | $1.34M(-92.7%) | - | - |
| Jan 2007 | $18.34M(+1240.5%) | - | - |
| Jan 2006 | $1.37M(-94.7%) | - | - |
| Jan 2005 | $25.81M(>+9900.0%) | - | - |
| Jan 2004 | $249.60K | - | - |
FAQ
- What is Summit Therapeutics Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. annual cash from financing year-on-year change?
- What is Summit Therapeutics Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. quarterly cash from financing year-on-year change?
- What is Summit Therapeutics Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. TTM cash from financing year-on-year change?
What is Summit Therapeutics Inc. annual cash from financing?
The current annual cash from financing of SMMT is $381.23M
What is the all-time high annual cash from financing for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high annual cash from financing is $620.24M
What is Summit Therapeutics Inc. annual cash from financing year-on-year change?
Over the past year, SMMT annual cash from financing has changed by +$294.71M (+340.66%)
What is Summit Therapeutics Inc. quarterly cash from financing?
The current quarterly cash from financing of SMMT is $34.66M
What is the all-time high quarterly cash from financing for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high quarterly cash from financing is $497.17M
What is Summit Therapeutics Inc. quarterly cash from financing year-on-year change?
Over the past year, SMMT quarterly cash from financing has changed by -$177.74M (-83.68%)
What is Summit Therapeutics Inc. TTM cash from financing?
The current TTM cash from financing of SMMT is $14.59M
What is the all-time high TTM cash from financing for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high TTM cash from financing is $647.48M
What is Summit Therapeutics Inc. TTM cash from financing year-on-year change?
Over the past year, SMMT TTM cash from financing has changed by -$402.54M (-96.50%)